SCHEMBL19464037

SCHEMBL19464037

CCOC(=O)c1cnc2c(Br)c(C)nn2c1CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.52
▸ ALDH1A1 P00352 7/20 0.52
▸ HSD17B10 Q99714 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ TSHR P16473 2/20 0.49
▸ NPC1 O15118 6/20 0.48
▸ RAB9A P51151 6/20 0.48
▸ HPGD P15428 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ CSNK1D P48730 1/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MEN1 O00255 2/20 0.44
▸ POLB P06746 3/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19492617 0.88 KDM4E (0.48) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19492633 0.86 KDM4E (0.53) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19492504 0.85 KDM4E (0.56) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19492634 0.84 KDM4E (0.51) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19463663 0.82 KDM4E (0.50) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19463513 0.82 KDM4E (0.50) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19463510 0.81 ALDH1A1 (0.56) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19464210 0.81 KDM4E (0.48) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19464231 0.78 KDM4E (0.53) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL19463241 0.74 CYP1A2 (0.52) KDM4EALDH1A1HSD17B10MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3442974-B1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-06-07 — — EP disclosed
EP-3442974-B1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-06-07 — — EP disclosed
CN-109071545-B Novel pyrazolopyrimidine derivatives 拜耳动物保健有限责任公司 2021-08-03 — — CN disclosed
US-11001590-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-05-11 — — US disclosed
US-11001590-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-05-11 — — US disclosed
US-10934301-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-03-02 — — US disclosed
US-10934301-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-03-02 — — US disclosed
US-20200299299-A1 NEW PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-09-24 — — US disclosed
US-20200299299-A1 NEW PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-09-24 — — US disclosed
US-20200239482-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-07-30 — — US disclosed
US-20200239482-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-07-30 — — US disclosed
US-10604525-B2 Pyrazolopyrimidine derivatives BAYAL ANIMAL HEALTH GMBH (DE) 2020-03-31 — — US disclosed
US-20190071447-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-03-07 — — US disclosed
US-20190071447-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-03-07 — — US disclosed
EP-3442974-A1 PYRAZOLOPYRIMIDINE DERIVATIVES Bayer Animal Health GmbH (DE) 2019-02-20 — — EP disclosed
WO-2017178416-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2017-10-19 — — WO disclosed
WO-2017178416-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2017-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10604525-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 KDM4E 1438/4885ALDH1A1 1297/4885HSD17B10 4478/4885
US-11001590-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 KDM4E 1445/4885ALDH1A1 1228/4885HSD17B10 4479/4885
US-20190071447-A1 PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 KDM4E 1438/4885ALDH1A1 1297/4885HSD17B10 4478/4885
US-20200239482-A1 PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 KDM4E 1445/4885ALDH1A1 1228/4885HSD17B10 4479/4885
US-10934301-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 KDM4E 1445/4885ALDH1A1 1228/4885HSD17B10 4479/4885
US-20200299299-A1 NEW PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 KDM4E 1658/4885ALDH1A1 1241/4885HSD17B10 4590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback